- ICH GCP
- US-Register für klinische Studien
- Klinische Studie NCT03752047
Can Respiratory Rate Predict the Risk of Deterioration of Septic Patients
The primary objective is to determine if the trend in Respiratory Rate measurements provided by the device under investigation can be used to predict an increase in Sequential/Sepsis-related Organ Failure Assessment (SOFA) score.
The RR trend will be measured as the difference between the RR recorded by the device at a point 15 minutes after commencement of treatment, as per the standard of care for patients suspected of being septic, and a point 3 hours following this.
Studienübersicht
Status
Bedingungen
Detaillierte Beschreibung
The primary objective is to determine if the trend in Respiratory Rate measurements provided by the device under investigation can be used to predict an increase in Sequential/Sepsis-related Organ Failure Assessment (SOFA) score.
The RR trend will be measured as the difference between the RR recorded by the device at a point 15 minutes after commencement of treatment, as per the standard of care for patients suspected of being septic, and a point 3 hours following this.
Secondary objective The secondary objective is to test if Respiratory Rate can help identify patients at increased risk of 30 day mortality.
The null Hypotheses of the planned comparison is that there is no difference in the RR trend in the 3 hours following commencement of treatment for sepsis in subjects who have an increase in SOFA score by 2 or more points and those who have a change in SOFA score of +1 or less.
The change in SOFA score will be measured at point of commencement of treatment and at 6 hours following commencement of treatment, or nearest available SOFA score determination.
Respiratory Rate captured during admission could have a predictive course for cohort of interest
The time points for reviewing the RR will be as follows:
(i) The last measurement (ii) The trend over 3 hours following commencement of treatment as per the standard of care for patients suspected of being septic.
(iii) The trend over the entire duration of admission
Studientyp
Einschreibung (Tatsächlich)
Kontakte und Standorte
Studienorte
-
-
South West Jutland
-
Esbjerg, South West Jutland, Dänemark, DK-6700
- Hospital of South West Jutland, Department of Emergency Medicine
-
-
Teilnahmekriterien
Zulassungskriterien
Studienberechtigtes Alter
Akzeptiert gesunde Freiwillige
Studienberechtigte Geschlechter
Probenahmeverfahren
Studienpopulation
Beschreibung
Inclusion criteria
- ≥ 18 Years
- Admitted for a minimum of 12 hours
- Have been diagnosed with sepsis
Sepsis diagnosis confirmed by documented or suspected infection (ordering of blood culture or other microbiological investigation by the clinician) and ≥1 of the following presenting within the first 4 hours of admission:
- Fever or hypothermia, Core temperature > 38.3 or < 36 °C
- Heart rate > 90/min
- Respiratory rate > 20/min
- Altered consciousness/mental state, defined as GCS < 15
- Hyperglycemia, (BS > 6.7 mmol/L non-diabetic)
- LKC > 12 *10^9 or < 4*10^9,
- Normal LKC with > 10 % immature cells,
- CRP > highest normal local lab. Interval
- Hypotension: Systolic BP <90 mmHg, or drop in systolic BP > 40
- Hypoxemia: PaO2 < 8.5 Kpa or PaO2/FiO2 < 40 or tissue perfusion: P-lactate > 1.6
- Creatinine . 177 µmol/L
- Acute oliguria (Diuresis per hour ,0.5 ml/kg/t or 45 ml/t in 2 hours)
- Coagulopathy: Spontaneous INR > 1.5, or apt > 60 sec, thrombocytopenia
- Paralytic ileus (absence of bowel sounds)
- Hyperbilirubinemia > 34µmol/L
- Are willing to voluntarily sign a statement of informed consent to participate in this investigation
Exclusion criteria
- Allergic to medical grade skin adhesive
- Pregnant women during second and third trimester
- Continuous long term steroid use. Defined as not using steroids in the 4 weeks previous to enrolment
- Patients under the influence of substance abuse (drug or alcohol) that may interfere with their ability to cooperate and comply with the investigation procedures
- Any disorder, including cognitive dysfunction, which would affect the ability to accurately complete questionnaires and freely give full informed consent. This will be determined by the Abbreviated Mental Test Score (AMT) Cannot be followed a second time if admitted again at a later date during the study period
Studienplan
Wie ist die Studie aufgebaut?
Designdetails
Kohorten und Interventionen
Gruppe / Kohorte |
|---|
|
Suspicion of Sepsis
Patients who are admitted and are diagnosed with sepsis will be recruited for this investigation.
|
Was misst die Studie?
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
RespiraSense triggered escalation in SOFA score
Zeitfenster: 15 minutes after commencement of treatment, as per the standard of care for patients suspected of being septic, and a point 3 hours following this.
|
Escalation of SOFA score by 2 or more points.
The primary endpoint will be evaluated with an ANCOVA with escalation of SOFA score by 2 or more points as a factor and mean RR in the first hour of treatment as a covariate.
|
15 minutes after commencement of treatment, as per the standard of care for patients suspected of being septic, and a point 3 hours following this.
|
Sekundäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Upward trend in Respiratory Rate as a predictor of 30 day mortality
Zeitfenster: 30 days after discharge
|
The secondary endpoint is the 30 day mortality rate after discharge.
|
30 days after discharge
|
Andere Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Upward trend in Respiratory Rate as a predictor of 30 day readmission.
Zeitfenster: 30 days after discharge
|
The secondary endpoint is the 30 day readmission rate after discharge.
|
30 days after discharge
|
Mitarbeiter und Ermittler
Sponsor
Mitarbeiter
Studienaufzeichnungsdaten
Haupttermine studieren
Studienbeginn (Tatsächlich)
Primärer Abschluss (Tatsächlich)
Studienabschluss (Tatsächlich)
Studienanmeldedaten
Zuerst eingereicht
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst gepostet (Tatsächlich)
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Tatsächlich)
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Zuletzt verifiziert
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Andere Studien-ID-Nummern
- PMD-CS-006ii
Plan für individuelle Teilnehmerdaten (IPD)
Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?
Beschreibung des IPD-Plans
Arzneimittel- und Geräteinformationen, Studienunterlagen
Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt
Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .
Klinische Studien zur Sepsis
-
University of California, San FranciscoNational Cancer Institute (NCI)RekrutierungSepsis | Sepsis, schwer | Sepsis und septischer Schock | Sepsis auf der Intensivstation | Sepsis, septischer Schock | Sepsis, schwere Sepsis und septischer Schock | Sepsis mit multipler Organdysfunktion (MOD) | Sepsis mit akuter OrgandysfunktionVereinigte Staaten
-
Assiut UniversityNoch keine RekrutierungSepsis-induzierte Myokarddysfunktion | Sepsis induzierte KardiomyopathieÄgypten
-
University of Kansas Medical CenterUniversity of KansasRekrutierungSepsis | Septischer Schock | Sepsis-Syndrom | Sepsis, schwer | Bakterielle Sepsis | Sepsis-BakterämieVereinigte Staaten
-
Jip GroenInBiomeRekrutierungMikrobielle Besiedlung | Neonatale Infektion | Neonatale Sepsis, früher Beginn | Mikrobielle Krankheit | Klinische Sepsis | Kultur-negative neonatale Sepsis | Neonatale Sepsis, später Beginn | Kulturpositive neonatale SepsisNiederlande
-
The University of QueenslandRoyal Brisbane and Women's HospitalUnbekannt
-
Karolinska InstitutetÖrebro University, SwedenAbgeschlossenSepsis | Sepsis-Syndrom | Sepsis, schwerSchweden
-
Ohio State UniversityAbgeschlossenSepsis, schwere Sepsis und septischer SchockVereinigte Staaten
-
University of LeicesterUniversity Hospitals, Leicester; The Royal College of AnaesthetistsAbgeschlossenSepsis | Septischer Schock | Schwere Sepsis | Sepsis-SyndromVereinigtes Königreich
-
Beckman Coulter, Inc.Biomedical Advanced Research and Development AuthorityAnmeldung auf EinladungSchwere Sepsis | Schwere Sepsis ohne septischen SchockVereinigte Staaten
-
Indonesia UniversityAbgeschlossenSchwere Sepsis mit septischem Schock | Schwere Sepsis ohne septischen SchockIndonesien